Foamable composition combining a polar solvent and a hydrophobic carrier
First Claim
1. A method of treating or alleviating a disorder, the method comprising:
- (a) releasing a foamable composition from a pressurized container to form a breakable foam that is stable at skin temperature and breaks upon application of shear force, said foamable composition comprising at least one liquefied or compressed gas propellant and a therapeutic composition comprising;
(1) a liquid organic carrier, at a concentration of about 10% to about 70% by weight of the therapeutic composition, wherein said liquid organic carrier comprises;
i. at least one liquid hydrophobic organic carrier; and
ii. a liquid polar solvent comprising ethanol and glycerin;
wherein the hydrophobic organic carrier comprises isopropyl myristate;
wherein the weight ratio between the liquid polar solvent and the at least one liquid hydrophobic organic carrier is between about 1;
4 and about 4;
1;
(2) at least one surface-active agent selected from the group consisting of at least one non-ionic surface-active agent and a mixture of a non-ionic surface-active agent and an ionic surface-active agent, wherein the ratio of the non-ionic surface-active agent to the ionic surface-active agent is about 6;
1 or greater than 6;
1;
(3) at least one polymeric agent selected from the group consisting of a bioadhesive agent, a gelling agent, a film forming agent, a phase change agent, and any mixtures of two or more thereof;
(4) water; and
(5) an active agent comprising coal tar or a coal tar extract or a tincture dissolved in all or part of the liquid polar solvent;
wherein the at least one liquefied or compressed gas propellant is at a concentration of about 3% to about 25% by weight of the foamable composition,(b) applying the breakable foam to a target area having a dermatological or mucosal disorder;
the disorder being selected from the group consisting of eczema, psoriasis, pruritis, dandruff, seborrhoeic dermatitis, and combinations of two or more thereof; and
(c) collapsing the breakable foam by applying shear force, wherein the foam is absorbed into the target area.
8 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to a foamable vehicle or cosmetic or pharmaceutical composition, comprising: (1) an organic carrier, at a concentration of 10% to 70% by weight, wherein said organic carrier concurrently comprises: (i) at least one hydrophobic organic carrier, and (ii) at least one polar solvent; (2) at least one surface-active agent; (3) water; and (4) at least one liquefied or compressed gas propellant at a concentration of 3% to 25% by weight of the total composition.
The present invention further provides a method of treating, alleviating or preventing a disorder of mammalian subject, comprising administering the above-mentioned compositions to an afflicted target site.
994 Citations
51 Claims
-
1. A method of treating or alleviating a disorder, the method comprising:
-
(a) releasing a foamable composition from a pressurized container to form a breakable foam that is stable at skin temperature and breaks upon application of shear force, said foamable composition comprising at least one liquefied or compressed gas propellant and a therapeutic composition comprising; (1) a liquid organic carrier, at a concentration of about 10% to about 70% by weight of the therapeutic composition, wherein said liquid organic carrier comprises; i. at least one liquid hydrophobic organic carrier; and ii. a liquid polar solvent comprising ethanol and glycerin; wherein the hydrophobic organic carrier comprises isopropyl myristate; wherein the weight ratio between the liquid polar solvent and the at least one liquid hydrophobic organic carrier is between about 1;
4 and about 4;
1;(2) at least one surface-active agent selected from the group consisting of at least one non-ionic surface-active agent and a mixture of a non-ionic surface-active agent and an ionic surface-active agent, wherein the ratio of the non-ionic surface-active agent to the ionic surface-active agent is about 6;
1 or greater than 6;
1;(3) at least one polymeric agent selected from the group consisting of a bioadhesive agent, a gelling agent, a film forming agent, a phase change agent, and any mixtures of two or more thereof; (4) water; and (5) an active agent comprising coal tar or a coal tar extract or a tincture dissolved in all or part of the liquid polar solvent; wherein the at least one liquefied or compressed gas propellant is at a concentration of about 3% to about 25% by weight of the foamable composition, (b) applying the breakable foam to a target area having a dermatological or mucosal disorder;
the disorder being selected from the group consisting of eczema, psoriasis, pruritis, dandruff, seborrhoeic dermatitis, and combinations of two or more thereof; and(c) collapsing the breakable foam by applying shear force, wherein the foam is absorbed into the target area. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51)
-
Specification